Related Experiment Videos
[Epidural spinal cord stimulation in chronic refractory angina pectoris]
Rigmor Myran1, Jan V Jørgensen, Rune Wiseth
1Nevrokirurgisk avdeling, St. Olavs Hospital, 7006 Trondheim. rigmor.myran@medisin.ntnu.no
Summary
Spinal cord stimulation (SCS) offers a positive alternative for chronic refractory angina pectoris, providing significant symptom relief and a low complication rate in patients unresponsive to conventional treatments.
Area of Science:
- Cardiovascular Medicine
- Neurosurgery
- Pain Management
Context:
- Chronic refractory angina pectoris (CRAP) presents a significant challenge due to persistent coronary insufficiency unresponsive to standard therapies.
- Limited treatment options exist for CRAP patients, necessitating exploration of alternative interventions.
- Spinal cord stimulation (SCS) has emerged as a documented treatment modality for refractory angina.
Purpose:
- To evaluate the efficacy and safety of spinal cord stimulation (SCS) in patients with chronic refractory angina pectoris (CRAP).
- To present the "beginners' experience" with SCS implantation and long-term follow-up.
- To assess symptomatic improvement and complication rates associated with SCS in this patient cohort.
Summary:
- A cohort of 21 patients (17 men, 4 women; median age 73) with severe CRAP (CCS class III-IV) underwent SCS implantation between 1996 and 2001.
- After a median follow-up of 27 months, 71% of patients reported symptomatic improvement, with a reduction in Canadian Cardiovascular Society (CCS) class from 3.5 to 2.2 and decreased nitroglycerin use.
- The study reported a low complication rate, with lead fracture in two patients and electrode displacement in one, while 81% of patients survived.
Impact:
- Spinal cord stimulation (SCS) demonstrates potential as a viable alternative treatment for chronic refractory angina pectoris (CRAP).
- The positive outcomes, including substantial symptomatic relief and a low complication rate, support the wider adoption of SCS in Norway.
- Establishing SCS as a treatment option can benefit a growing patient population suffering from refractory angina.